LASA SUPERGENERICS LTD (LASA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 2016, Lasa Supergenerics Ltd is in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc.[1]

LASAUpdated 25 Jul 2026, 18:31

Lasa Supergenerics Ltd

Market Cap

₹34.8Cr.

Current Price

₹6.94

High / Low

₹14.1/5.65

Book Value₹9.90
Dividend Yield0.00%
ROCE-18.2%
ROE-19.6%
Face Value₹10.0

About

Incorporated in 2016, Lasa Supergenerics Ltd is in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Mar 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days64636245275071341
Inventory Days939090101564648928428
Days Payable71102170130416832683532
Cash Conversion Cycle8751-18164228223753-4
Working Capital Days15-1-52-133512-17-4437-102
ROCE %42%13%-4%7%17%1%-12%-6%-1%-18%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 25 July 2026 at 18:31


Designed & Shipped by Harshit Bansal